Population
From March 5, 2019, to October 8, 2020, 200 patients consented to this study; 195 were randomized, and 189 completed all follow-up assessments (Trial chart.Patient Characteristics (Intention-to-Treat Population)Values in parentheses are ranges.Reported as numbers of patients, with percentages in parentheses.Reported as medians, with interquartile ranges in parentheses.ISUP = International Society of Urological Pathology.The median follow-up period for the ITT population was 8.3 mo (range, 2.9–16.1 mo), as its duration was extended because of the COVID-19 pandemic.